Skip to content

Second company halts CCR5 inhibitor study in another blow to new drug class

Unusual side-effects or drug interactions? UK's safety regulator wants to hear from you

Report higlights increase in HIV infections amongst IDUs in UK

Vitamin D boosts anti-TB immunity, now being tested as add-on to TB therapy

Main article: Clinical Care Options discussion on mother-to-child transmission

Blood concentrations of efavirenz predict who will develop central nervous system side-effects

Tipranavir receives European marketing approval

HIV has led to discrimination by medical professionals say 26% of HIV-positive Americans

Highly infectious TB cases increase by one third in England since 1999